Free Trial
NYSE:BHC

Bausch Health Cos (BHC) Stock Price, News & Analysis

Bausch Health Cos logo
$6.40 -0.08 (-1.16%)
Closing price 10/7/2025 03:59 PM Eastern
Extended Trading
$6.42 +0.03 (+0.47%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bausch Health Cos Stock (NYSE:BHC)

Advanced

Key Stats

Today's Range
$6.36
$6.51
50-Day Range
$5.71
$8.34
52-Week Range
$4.25
$9.85
Volume
858,275 shs
Average Volume
1.78 million shs
Market Capitalization
$2.37 billion
P/E Ratio
24.60
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Hold

Company Overview

Bausch Health Cos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

BHC MarketRank™: 

Bausch Health Cos scored higher than 93% of companies evaluated by MarketBeat, and ranked 71st out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch Health Cos has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Bausch Health Cos has a consensus price target of $9.00, representing about 40.7% upside from its current price of $6.40.

  • Amount of Analyst Coverage

    Bausch Health Cos has only been the subject of 1 research reports in the past 90 days.

  • Read more about Bausch Health Cos' stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch Health Cos are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch Health Cos is 24.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch Health Cos is 24.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.60.

  • Read more about Bausch Health Cos' valuation and earnings.
  • Percentage of Shares Shorted

    2.42% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently decreased by 4.00%, indicating that investor sentiment is improving.
  • Dividend Yield

    Bausch Health Cos does not currently pay a dividend.

  • Dividend Growth

    Bausch Health Cos does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.42% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently decreased by 4.00%, indicating that investor sentiment is improving.
  • News Sentiment

    Bausch Health Cos has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bausch Health Cos this week, compared to 5 articles on an average week.
  • Search Interest

    45 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.
  • MarketBeat Follows

    8 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch Health Cos insiders have bought more of their company's stock than they have sold. Specifically, they have bought $333,757,793.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    19.97% of the stock of Bausch Health Cos is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bausch Health Cos' insider trading history.
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BHC Stock News Headlines

Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

BHC Stock Analysis - Frequently Asked Questions

Bausch Health Cos' stock was trading at $8.06 on January 1st, 2025. Since then, BHC stock has decreased by 20.7% and is now trading at $6.3950.

Bausch Health Cos Inc. (NYSE:BHC) issued its quarterly earnings results on Wednesday, July, 30th. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.97 by $0.07. The business earned $2.57 billion during the quarter, compared to the consensus estimate of $2.47 billion. Bausch Health Cos had a negative trailing twelve-month return on equity of 852.36% and a net margin of 0.99%.
Read the conference call transcript
.

Bausch Health Cos' top institutional investors include Sanders Morris Harris LLC (0.01%). Insiders that own company stock include John Paulson and Seana Carson.
View institutional ownership trends
.

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
7/30/2025
Today
10/08/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:BHC
CIK
885590
Employees
20,700
Year Founded
1959

Price Target and Rating

High Price Target
$10.00
Low Price Target
$8.00
Potential Upside/Downside
+40.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
24.60
Forward P/E Ratio
1.45
P/E Growth
N/A
Net Income
-$46 million
Net Margins
0.99%
Pretax Margin
2.85%
Return on Equity
-852.36%
Return on Assets
5.25%

Debt

Debt-to-Equity Ratio
141.90
Current Ratio
1.31
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$9.63 billion
Price / Sales
0.25
Cash Flow
$7.61 per share
Price / Cash Flow
0.84
Book Value
($0.89) per share
Price / Book
-7.19

Miscellaneous

Outstanding Shares
370,350,000
Free Float
296,389,000
Market Cap
$2.37 billion
Optionable
Optionable
Beta
0.43

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:BHC) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners